Treatment of Mood Disorders Secondary to Medical Conditions or Medications
First-line treatment for mood disorders secondary to medical conditions or medications should focus on addressing the underlying medical cause or modifying the causative medication before initiating specific psychiatric treatments. 1
Initial Assessment and Management
- Treat medical causes of depressive symptoms (e.g., unrelieved pain, fatigue) and delirium (e.g., infection, electrolyte imbalance) as the first step in management 1
- Review current medications and identify those that may be contributing to mood symptoms, with consideration for dose adjustment or medication substitution when possible 1
- For mood disorders resulting from medication side effects, consider:
Pharmacological Treatment Approaches
For optimal management of depressive symptoms or diagnosed mood disorder secondary to medical conditions, use pharmacologic interventions delivered by appropriately trained individuals 1
When selecting an antidepressant, consider:
For depression secondary to medical conditions, SSRIs are commonly used first-line agents due to their favorable side effect profile 1, 2
For patients with comorbid anxiety symptoms, which commonly occur alongside depression (50-60% of cases), treating the depression first is the usual practice 1
Non-Pharmacological Approaches
- Psychotherapy, psychoeducational therapy, cognitive-behavioral therapy (CBT), and exercise can be effective for mood disorders secondary to medical conditions 1
- CBT has shown effectiveness equivalent to antidepressant medications and may be particularly useful when medication options are limited due to interactions or contraindications 1, 2
- Offer support and provide education about depression and its management to all patients and their families 1
- Include information about specific symptoms and what degree of symptom worsening warrants contacting healthcare providers 1
Special Considerations for Specific Populations
Cancer Patients
- In cancer patients with mood disorders, psychotherapy with or without anxiolytics or antidepressants is recommended after eliminating medical causes 1
- Follow-up should occur with the primary oncology team if symptoms respond to initial treatment 1
- If no response is noted, patients should be reevaluated and treated with different medications with continued psychotherapy, support, and education 1
Children and Adolescents
- For children and adolescents with mood disorders secondary to medical conditions or medications, careful assessment is needed before initiating psychotropic medications 1
- Avoid unnecessary polypharmacy while ensuring adequate treatment of symptoms 1
- When discontinuing medications, develop a specific plan rather than abrupt cessation 1
Stepped Care Approach
Implement a stepped care model and tailor interventions based on:
- Current symptom severity and presence/absence of DSM-5 diagnosis 1
- Level of functional impairment in major life areas 1
- Presence or absence of risk factors 1
- History of and response to previous treatments 1
- Patient preference 1
- Persistence of symptoms after initial treatment 1
Monitoring and Follow-up
- Use standardized assessment tools such as the Patient Health Questionnaire-9 (PHQ-9), Hamilton Depression Rating Scale (HAM-D), or Hospital Anxiety and Depression Scale (HADS) to monitor treatment response 1, 2
- Continue treatment for at least 4-9 months after satisfactory response for first episodes, with longer duration beneficial for recurrent episodes 2, 3
- For any patient identified as at risk of harm to self or others, refer to appropriate services for emergency evaluation 1
Common Pitfalls to Avoid
- Failing to identify and address the underlying medical cause or medication side effect 1
- Mistaking behavioral and emotional reactions to psychosocial stressors as symptoms of an underlying biological illness 1
- Using medications to address all of a patient's symptoms when psychosocial interventions may be more appropriate for some symptoms 1
- Inadequate dosing or premature discontinuation before therapeutic effects are achieved (typically 4-6 weeks) 2
- Not continuing treatment long enough to prevent relapse 2